E-MTAB-1204 - ChIP-seq of human cells from a primary prostate cancer with poor outcome and metastatic LNCaP cells in basal condition and after 17b-Estradiol (E2) treatment

Status
Released on 4 November 2013, last updated on 23 July 2014
Organism
Homo sapiens
Samples (8)
Protocols (5)
Description
ChIP-Sequencing using antibody to eNOS in cells from a primary prostate cancer with poor outcome and metastatic LNCaP cells, in basal condition and after E2 treatment
Experiment types
ChIP-seq, ChiP-seq, compound treatment, in vitro
Contact
Citation
Estrogen-dependent dynamic profile of eNOS-DNA associations in prostate cancer. Nanni S, Aiello A, Re A, Guffanti A, Benvenuti V, Colussi C, Castro-Vega LJ, Felsani A, Londono-Vallejo A, Capogrossi MC, Bacchetti S, Gaetano C, Pontecorvi A, Farsetti A. PLoS One 8(5):e62522 (2013), Europe PMC 23658738
MINSEQE
Exp. designProtocolsFactorsProcessedSeq. reads
Files
Investigation descriptionE-MTAB-1204.idf.txt
Sample and data relationshipE-MTAB-1204.sdrf.txt
Links